Public Profile

Tanner Pharma

Tanner Pharma Group, commonly referred to as Tanner Pharma, is a leading provider of global access solutions for patients in need of critical medications. Headquartered in the United States, the company operates extensively across North America, Europe, and Asia, focusing on the pharmaceutical industry. Founded in 2008, Tanner Pharma has achieved significant milestones, including the development of innovative programmes that facilitate access to life-saving therapies. The company specialises in providing comprehensive services such as patient access programmes, clinical trial support, and supply chain management. What sets Tanner Pharma apart is its commitment to ensuring that patients receive the medications they require, regardless of geographical or financial barriers. With a strong market position and a reputation for excellence, Tanner Pharma continues to make a meaningful impact in the healthcare landscape.

DitchCarbon Score

How does Tanner Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Tanner Pharma's score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

Tanner Pharma's reported carbon emissions

Tanner Pharma, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their current impact on carbon emissions or their strategic approach to climate change. However, the absence of data does not preclude the possibility of ongoing efforts in sustainability and emissions reduction within the pharmaceutical industry. As the sector increasingly prioritises environmental responsibility, Tanner Pharma may be aligning with broader industry trends aimed at reducing carbon footprints and enhancing climate resilience. Further information would be necessary to provide a comprehensive overview of their commitments and performance in this area.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Tanner Pharma's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Tanner Pharma is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Tanner Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Guzen Development

US
Health Services
Updated 10 days ago

RED DESIGN GROUP

US
Health Services
Updated 10 days ago

STE Shipping and Intermodal

NL
Health Services
Updated 10 days ago

MEDLAW SERVICES

US
Health Services
Updated 10 days ago

Stüken

DE
Health Services
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers